Movano Return on Tangible Equity 2020-2024 | MOVE

Current and historical return on tangible equity values for Movano (MOVE) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Movano Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2024-09-30 $-0.03B $0.01B -344.83%
2024-06-30 $-0.03B $0.02B -450.00%
2024-03-31 $-0.03B $-0.00B -560.00%
2023-12-31 $-0.03B $0.00B -362.50%
2023-09-30 $-0.03B $0.01B -335.14%
2023-06-30 $-0.03B $0.01B -263.83%
2023-03-31 $-0.03B $0.01B -229.63%
2022-12-31 $-0.03B $0.01B -177.14%
2022-09-30 $-0.03B $0.02B -122.11%
2022-06-30 $-0.03B $0.02B -84.75%
2022-03-31 $-0.02B $0.03B -65.25%
2021-12-31 $-0.02B $0.03B -59.63%
2021-09-30 $-0.02B $0.04B -76.67%
2021-06-30 $-0.02B $0.04B -117.07%
2021-03-31 $-0.02B $0.05B -246.15%
2020-12-31 $-0.02B $-0.01B 1000.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.023B $0.000B
Movano Inc. is a health technology company. It engages in designing devices which empower individuals to optimize their health in order to prevent and better manage chronic diseases. Movano Inc. is based in PLEASANTON, CA.
Stock Name Country Market Cap PE Ratio
Tempus AI (TEM) United States $9.226B 0.00
Inspire Medical Systems (INSP) United States $5.656B 176.38
Hims & Hers Health (HIMS) United States $5.534B 140.72
Enovis (ENOV) United States $2.608B 17.68
Privia Health (PRVA) United States $2.587B 215.60
IRhythm Technologies (IRTC) United States $2.316B 0.00
Azenta (AZTA) United States $2.209B 110.15
Omnicell (OMCL) United States $2.116B 69.23
10x Genomics (TXG) United States $1.732B 0.00
Clover Health Investments (CLOV) United States $1.689B 0.00
Schrodinger (SDGR) United States $1.518B 0.00
Phreesia (PHR) United States $1.148B 0.00
Butterfly Network (BFLY) United States $0.690B 0.00
Standard BioTools (LAB) United States $0.596B 0.00
Talkspace (TALK) United States $0.583B 0.00
Fulgent Genetics (FLGT) United States $0.547B 0.00
Definitive Healthcare (DH) United States $0.505B 87.40
Health Catalyst (HCAT) United States $0.495B 0.00
Pulmonx (LUNG) United States $0.268B 0.00
TruBridge (TBRG) United States $0.247B 71.91
SOPHiA GENETICS SA (SOPH) Switzerland $0.209B 0.00
American Well (AMWL) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.112B 0.00
P3 Health Partners (PIII) United States $0.076B 0.00
HeartBeam (BEAT) United States $0.074B 0.00
111 (YI) China $0.052B 0.00
CareCloud (CCLD) United States $0.046B 0.00
Outset Medical (OM) United States $0.044B 0.00
SHL Telemedicine (SHLT) Israel $0.042B 0.00
Zepp Health (ZEPP) China $0.037B 0.00
Bullfrog AI Holdings (BFRG) United States $0.017B 0.00
Streamline Health Solutions (STRM) United States $0.013B 0.00
Strata Skin Sciences (SSKN) United States $0.013B 0.00
MSP Recovery (LIFW) United States $0.013B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.011B 0.00
Precipio (PRPO) United States $0.009B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Predictive Oncology (POAI) United States $0.005B 0.00
Syra Health (SYRA) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.002B 0.00
Zhongchao (ZCMD) China $0.002B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00